Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Publication Date	November 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	55
ISBN Number	not applicable
Product Code	GMD07665

Price

£1,960.00
approximately: $2,997 | €2,186

PDF

Order above formats by FAX

Summary

Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for indepth information and data relating to the Mexico drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key subsegments of the drug delivery devices in Mexico

Scope

The report provides drug delivery devices information broken down into detailed categories and segments in Mexico.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in Mexico.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
- 3.1 lrug delivery devices
- 3.2 Inhalation Systems
  - 3.2.1 Metered Dose Inhaler
  - 3.2.2 Dry powder inhaler
- 3.3 Infusion Systems
  - 3.3.1 Infusion pumps
  - 3.3.2 Syringe pumps
  - 3.3.3 Disposable Infusion sets
4 Healthcare Sector Review
5 Regulation System
- 5.1 Device Classification
- 5.2 Registration Process
- 5.3 Labeling Requirements
- 5.4 Import Documentation
6 Pricing and Reimbursement
7 Distribution Structure
8 Drug Delivery Devices In Mexico
- 8.1 Drug Delivery Devices Cross Country Comparison (20002012)
- 8.2 Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 20002012
- 8.3 Drug Delivery Devices, Mexico, Category Volume (Units), 20002012
- 8.4 Drug Delivery Devices, Mexico Company share (20062007)
9 Infusion Systems In Mexico
- 9.1 Infusion Systems Overall Revenue (20002012)
- 9.2 Infusion Systems Overall Volume (20002012)
- 9.3 Infusion Systems Average Price (20002012)
- 9.4 Infusion Systems Distribution Share (20062007)
- 9.5 Infusion Systems, Mexico, Company Share (20062007)
10 Inhalation Systems In Mexico
- 10.1 Inhalation Systems Overall Revenue (20002012)
- 10.2 Inhalation Systems Overall Volume (20002012)
- 10.3 Inhalation Systems Average Price (20002012)
- 10.4 Inhalation Systems Distribution Share (20062007)
- 10.5 Inhalation Systems, Mexico, Company Share (20062007)
11 3M Company Company Profile
- 11.1 Company Overview
- 11.2 Value Chain Analysis
  - 11.2.1 Manufacturing
  - 11.2.2 Product Development
  - 11.2.3 Sales and Marketing
12 AstraZeneca PLC Company Profile
- 12.1 Company Overview
13 Baxter International Inc. Company Profile
- 13.1 Company Overview
- 13.2 Value Chain Analysis
  - 13.2.1 Manufacturing
  - 13.2.2 Product Development
  - 13.2.3 Sales and Marketing
14 Boehringer Ingelheim GmbH Company Profile
- 14.1 Company Overview
- 14.2 Value Chain Analysis
  - 14.2.1 Manufacturing
  - 14.2.2 Product Development
  - 14.2.3 Sales and Marketing
15 GlaxoSmithKline plc Company Profile
- 15.1 Company Overview
16 Novartis Medical Nutrition Company Profile
- 16.1 Company Overview
- 17.1 Global Markets Direct Research Methodology
- 17.2 Coverage
- 17.3 Secondary Research
- 17.4 Primary Research
- 17.5 Models
- 17.6 Forecasts
- 17.7 Expert Panels
- 17.8 Currency Conversion
- 17.9 Contact Us
- 17.10 Disclaimer
1.1 List of Tables
- Table 1: Drug Delivery Devices Cross Country Comparison (20002012)
- Table 2: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 20002012
- Table 3: Drug Delivery Devices, Mexico, Portfolio Analysis, 20002012
- Table 4: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Historic, 20002007
- Table 5: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Forecast, 20072012
- Table 6: Drug Delivery Devices, Mexico, Category Volume (Units), 20002012
- Table 7: Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 20002007
- Table 8: Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 20072012
- Table 9: Drug Delivery Devices, Mexico Company share by Revenue ($ mn), 20062007
- Table 10: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Historic, 20002007
- Table 11: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 20072012
- Table 12: Infusion Systems, Mexico, Overall Volume (Units), Historic, 20002007
- Table 13: Infusion Systems, Mexico, Overall Volume (Units), Forecast, 20072012
- Table 14: Infusion Systems, Mexico, Average Price ($), Historic, 20002007
- Table 15: Infusion Systems, Mexico, Average Price ($), Forecast, 20072012
- Table 16: Infusion Systems, Mexico, Distribution Share by Revenue ($mn), 20062007
- Table 17: Infusion Systems, Mexico, Company Share by Revenue ($ mn), 20062007
- Table 18: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Historic, 20002007
- Table 19: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 20072012
- Table 20: Inhalation Systems, Mexico, Overall Volume (Units), Historic, 20002007
- Table 21: Inhalation Systems, Mexico, Overall Volume (Units), Forecast, 20072012
- Table 22: Inhalation Systems, Mexico, Average Price ($), Historic, 20002007
- Table 23: Inhalation Systems, Mexico, Average Price ($), Forecast, 20072012
- Table 24: Inhalation Systems, Mexico, Distribution Share by Revenue ($mn), 20062007
- Table 25: Inhalation Systems, Mexico, Company Share by Revenue ($ mn), 20062007
- Table 26: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.2 List of Figures
- Figure 1: Drug Delivery Devices Cross Country Comparison (20002012)
- Figure 2: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), 20002012
- Figure 3: Drug Delivery Devices, Mexico, Portfolio Analysis, 20002012
- Figure 4: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Historic, 20002007
- Figure 5: Drug Delivery Devices, Mexico, Overall Revenues ($ mn), Forecast, 20072012
- Figure 6: Drug Delivery Devices, Mexico, Category Volume (Units), 20002012
- Figure 7: Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 20002007
- Figure 8: Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 20072012
- Figure 9: Drug Delivery Devices, Mexico Company share (%), 2007
- Figure 10: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Historic, 20002007
- Figure 11: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 20072012
- Figure 12: Infusion Systems, Mexico, Company Share (%), 2007
- Figure 13: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Historic, 20002007
- Figure 14: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 20072012
- Figure 15: Inhalation Systems, Mexico, Overall Volume (Units), Historic, 20002007
- Figure 16: Inhalation Systems, Mexico, Overall Volume (Units), Forecast, 20072012
- Figure 17: Inhalation Systems, Mexico, Company Share (%), 2007
- Figure 18: 3M Healthcare Value Chain Analysis
- Figure 19: Baxter International Inc. Value Chain Analysis
- Figure 20: Boehringer Ingelheim GmbH Value Chain Analysis
- Figure 21: Global Markets Direct Methodology